world1 outlet covering thisCalibrating

Biogen stock rises on positive Alzheimer’s drug trial data

First publishedJul 14, 13:21 UTC

Last updatedJul 14, 15:09 UTC · 10m ago

1 outlets over time — hover a bar for its window & outletslast updated

Biogen stock rises on positive Alzheimer’s drug trial data

● Story signals

How strong is this topic?

6.0/10Significanceimpact & urgency

6.0/10Source trustoutlet authority

1Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

Biogen stock rises on positive Alzheimer’s drug trial data.

Reported by 1 outlet — Investing.com · Stock Market. See all sources ↓

Why it matters

A world story we're tracking; its significance and source trust firm up as more outlets confirm it.

In brief

What's the story?: Biogen stock rises on positive Alzheimer’s drug trial data.
How widely is it covered?: 1 outlet, average source rating 6.0/10.
When was it last updated?: 10m ago.

Different angles across outlets

Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

Coverage card1 outlet
1Coverage
Scouting report
Biogen stock rises on positive Alzheimer’s drug trial data
Sources1
TypeCoverage
Investing.com · Stock MarketJul 14, 13:21

Related in the knowledge graph

organizationAlzheimer organizationBiogen

Sources (1)

Avg source rating 6.0/10

Investing.com · Stock Market6

Processing cluster

A1A2A3B1B2B3

Share this article

X / Twitter LinkedIn WhatsApp

Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)

GPT Perplexity Gemini Claude